Traitements2programmes
Essais1liés
Publications1liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
API 31510The purpose of this study is to determine the safety and tolerability of pharmaceutical compound 31510 in a topical cream when applied to in situ cutaneous squamous cell carcinoma and to obtain preliminary efficacy data for the treatment of in situ cutaneous squamous cell carcinoma by Compound 31510 topical cream. Cancer Phase 1 À vérifier United States À vérifier
API 31510The purpose of this study is to determine the safety and tolerability of pharmaceutical compound 31510 in a topical cream when applied to in situ cutaneous squamous cell carcinoma and to obtain preliminary efficacy data for the treatment of in situ cutaneous squamous cell carcinoma by Compound 31510 topical cream. Cancer Phase 1 À vérifier United States À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
API 31510 Cancer Phase 1 NCT00652080 An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS) COMPLETED

Publications

1
MoléculeIndication / populationTitreJournalDate
API 31510 A Social Network Analysis of Tweets Related to Mandatory COVID-19 Vaccination in Poland. Vaccines